GLIOTWIN is a Virtual Human Twin project designed to address two persistent blind spots in high-grade glioma: the invisible margin beyond what MRI can detect and the invisible onset of the disease.
NAMs are reshaping biomedical research by offering more human-relevant approaches to studying disease and treatment response. Prof. Igor Balaž discusses how organoids, organ-on-chip systems, advanced data analysis, and digital twins can work together to improve preclinical research and drug development.
CancerScan brings together organoids, AI and tumour digital twins to advance precision oncology. In this podcast, Irena Milobratović and Prof. Igor Balaž discuss the project’s approach to predicting patient-specific treatment response and translating innovative research towards clinical practice.
Irena Milobratović speaks with Igor Balaž about BioMeld’s approach to biohybrid machine design and the role of AI, simulations, and human expertise in advancing this emerging technology.
The CancerScan Digital Twin System, developed by Neovivum Technologies within the EU-funded CancerScan project, has received EMA Breakthrough Device designation and will advance to structured expert guidance on its clinical and regulatory development pathway.
